Cholesterol and lipid medicines

Hypolipidaemic agents

Find reliable independent health and treatment information about the cholesterol and lipid medicines subcategory of medicines. This includes resources for consumers and health professionals.

The Cholesterol and lipid medicines subcategory of medicines is also known as anticholesteraemic agents, cholesterol lowering medicines, dyslipidaemia, medicines for, lipid-lowering medicines, lipid-modifying medicines and hypolipidaemic agents.

You can also search for an active ingredient, brand or other category of medicine using our Medicine Finder.

Latest information - cholesterol and lipid medicines

Audience:
       

For health professionals (Health professional development)
27 May 2014 This free online course on lipid management and cardiovascular risk is for students.
For health professionals (Health professional development)
23 May 2014 This free case study on cardiovascular disease and lipids is for GPs, pharmacists, nurses and students.
For health professionals (Health professional development)
23 May 2014 This free clinical e-audit on cardiovascular disease risk assessment and lipids is for GPs.
(Media release)
12 May 2014 NPS MedicineWise has welcomed the ABC’s ruling — published today — that its Catalyst program aired in October 2013 on statins and heart disease breached its own standards on impartiality.
(Consumer publication)
02 May 2014 Current clinical trial evidence does not support the use of Co-enzyme Q10 supplements to prevent muscle pain (myalgia), which is a known possible side effect of using statins.
(Media release)
14 Feb 2014 NPS MedicineWise is reminding health professionals that while various media reports have recently linked statins to a variety of adverse events and questioned their efficacy, these drugs remain one of the most effective strategies for reducing the risk of cardiovascular disease (CVD).
(Media release)
14 Feb 2014 NPS MedicineWise is reminding health professionals and the general public that the cholesterol-lowing medicines statins remain one of the most effective strategies for reducing the risk of heart attack and stroke.
For health professionals (Health professional publication)
01 Feb 2014 For people under 75, starting treatment with statins should be based on their absolute CVD risk. Find out who needs a risk calculation, who is assumed to be at high risk of cardiovascular events and what the treatment recommendations are.
(Media release)
06 Dec 2013 With the statins group of cholesterol-lowering medicines continuing to make headlines this week, independent organisation NPS MedicineWise has reviewed the latest clinical evidence and published a set of Frequently Asked Questions (FAQs) on its website addressing people’s key concerns.
(Media release)
02 Dec 2013 Cholesterol-lowering medicines known as statins top the list of the top 10 subsidised drugs in Australia again this year, according to data published in Australian Prescriber.

Active ingredients used in cholesterol and lipid medicines